Patients with a certain B-cell malignancy and abnormal liver function tests at diagnosis are at risk of shorter overall survival compared with those who have normal liver function. READ MORE
Research in Review
Researchers compared a treatment regimen including bortezomib with standard care practices to see which would be more cost effective for patients with mantle cell lymphoma.
Findings from a single-center analysis have shown that anthracycline-based therapies may produce better outcomes in patients age 80 years and older with diffuse large B-cell lymphoma (DLBCL), supporting data reported in previous clinical trials.
In a study published in the Journal of Clinical Oncology, researchers investigated the utility of PET imaging to guide response-adapted therapy for patients with advanced Hodgkin lymphoma.
SD-101, a novel immunotherapy drug for low-grade lymphoma, reported promising results from a phase 1/2 clinical trial.